Dr. Peter C. Albertsen MD

• 
  www.indianexpress.com/story/323084.html - [Cached Version]
  Published on: 6/15/2008    Last Visited: 6/15/2008  

  Dr Peter Albertsen, a prostate cancer specialist at the University of Connecticut, explains: While 10 per cent of men 55 and older find out they have prostate cancer, the cancer is lethal in no more than 25 per cent of them.So if finasteride reduced the prostate cancer's incidence by 30 per cent, about 7 per cent of men would get a cancer diagnosis and approximately 1.8 per cent instead of 2.5 per cent would have a lethal cancer.
  
  "Finasteride might make a difference, but only in a very small subset of men," Albertsen said.

• 
  www.nursesworldmag.com/health-news/print-this.cfm/id/58 - [Cached Version]
  Published on: 1/17/2008    Last Visited: 2/15/2008  

  "To me, this is a nightmare," said Dr. Peter C. Albertson, a surgery professor and prostate cancer specialist at the University of Connecticut."We are just feeding off of this cancer phobia."
  
  "We plan to offer the test now because we believe that some men and their physicians will want to take advantage of these findings -- knowing the test will be refined over time," Xu said.He said that the data used in the study focused on Swedish men, and further study is needed with different racial and ethnic groups.

• 
  www.independent.co.uk/opinion/columnists/miles-kington/ - [Cached Version]
  Published on: 1/22/2008    Last Visited: 1/24/2008  

  "It's the boutique medicine of the future," says Professor Peter C Albertsen.

• 
  www.urologytimes.com/urologytimes/issue/issueDetail.jsp - [Cached Version]
  Published on: 1/31/2007    Last Visited: 9/1/2007  

  Dr. Albertsen named medical director of UConn Medical Group
  
  Urologist Peter Albertsen, MD, has been named medical director of the UConn Medical Group, a 350-member multi-specialty physician practice, and James Thornton has been named director of the 224-bed John Dempsey Hospital, creating a new leadership team for the health center's clinical enterprise.

• 
  southflorida.bizjournals.com/southflorida/gen/company.h - [Cached Version]
  Last Visited: 6/11/2008  

  Peter C Albertsen [Chief of Urology, and Residency Program Director, University of Connecticut Health Center]

• 
  www.urologytimes.com/urologytimes/Enews/Dr-Albertsen-na - [Cached Version]
  Published on: 2/1/2007    Last Visited: 9/1/2007  

  Dr. Albertsen named medical director of UConn Medical Group
  ...
  Dr. Albertsen named medical director of UConn Medical Group
  ...
  Urologist Peter Albertsen, MD, has been named medical director of the UConn Medical Group, a 350-member multi-specialty physician practice, and James Thornton has been named director of the 224-bed John Dempsey Hospital, creating a new leadership team for the health center's clinical enterprise.
  ...
  Dr. Albertsen also serves as associate dean for clinical research planning and director of the urology residency program at the Health Center.He is a trustee of the American Board of Urology and immediate past president of the American Association of Clinical Urologists.
  ...
  Urologist Peter Albertsen, MD, has been named medical director of the UConn Medical Group, a 350-member multi-specialty physician practice, and James Thornton has been named director of the 224-bed John Dempsey Hospital, creating a new leadership team for the health center's clinical enterprise.

• 
  www.gadsdentimes.com/article/20080615/ZNYT04/806150336/ - [Cached Version]
  Published on: 6/15/2008    Last Visited: 6/15/2008  

  Dr. Peter Albertsen, a prostate cancer specialist at the University of Connecticut, explains: While 10 percent of men 55 and older find out they have prostate cancer, the cancer is lethal in no more than 25 percent of them.So if finasteride reduced the prostate cancer,s incidence by 30 percent, about 7 percent of men would get a cancer diagnosis and approximately 1.8 percent instead of 2.5 percent would have a lethal cancer.
  
  ,Finasteride might make a difference but only in a very small subset of men,, Dr. Albertsen said.
  
  And, he adds, the study did not look for a decline in death rates, and it is unlikely that any study ever will , it would take too long and be too expensive.

• 
  www.timesargus.com/apps/pbcs.dll/article?AID=/20080615/ - [Cached Version]
  Published on: 6/15/2008    Last Visited: 6/16/2008  

  Dr. Peter Albertsen, a prostate cancer specialist at the University of Connecticut, explains: While 10 percent of men 55 and older find out they have prostate cancer, the cancer is lethal in no more than 25 percent of them.So if finasteride reduced the prostate cancer's incidence by 30 percent, about 7 percent of men would get a cancer diagnosis and approximately 1.8 percent instead of 2.5 percent would have a lethal cancer.
  
  "Finasteride might make a difference, but only in a very small subset of men," Albertsen said.
  
  And, he adds, the study did not look for a decline in death rates, and it is unlikely that any study ever will - it would take too long and be too expensive.

• 
  www.western-star.com/l/content/oh/story/living/health/2 - [Cached Version]
  Published on: 1/17/2008    Last Visited: 1/25/2008  

  "It's the boutique medicine of the future," said Dr. Peter C. Albertsen, a surgery professor and prostate cancer specialist at the University of Connecticut.
  ...
  "To me, it is a nightmare," Albertsen said."We are just feeding off of this cancer phobia."

• 
  www.gadsdentimes.com/article/20080117/ZNYT04/801170342/ - [Cached Version]
  Published on: 1/17/2008    Last Visited: 1/19/2008  

  ,It,s the boutique medicine of the future,, said Dr. Peter C. Albertsen, a surgery professor and prostate cancer specialist at the University of Connecticut. ,We can know what diseases we will have to face in the rest of our lives.,

Page:  1 2 3 4 5